Skip to main content
logo
Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
110.33
-0.49 (-0.44%)
Aug 26, 2026, 10:49 AM EDT - Market open

Monopar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
74143613453140
Market Cap Growth
274.38%225.25%2552.79%-83.48%-24.23%-42.34%
Enterprise Value
606293128-31618
Last Close Price
110.8265.3022.001.7011.8516.05

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
5.683.172.440.913.042.13
P/TBV Ratio
5.683.172.440.913.042.13

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.00--0.00-
Net Debt / Equity Ratio
-1.02-1.02-1.09-1.30-1.30-1.07
Quick Ratio
33.4451.3311.464.144.1912.85
Current Ratio
33.5651.3511.484.174.2112.98
Return on Equity (ROE)
-19.50%-14.22%-51.42%-107.19%-72.45%-52.57%
Return on Assets (ROA)
-14.64%-10.39%-29.87%-53.66%-39.03%-30.51%
Return on Capital Employed (ROCE)
-16.90%-12.10%-29.40%-158.00%-104.30%-48.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.40%-3.14%-11.62%-166.13%-34.34%-22.52%
Buyback Yield / Dilution
-45.84%-95.53%-37.09%-8.70%-1.97%-13.82%
SEC Filings: 10-K · 10-Q